Sponsor Pipeline

Yunlong Wang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-21 NCT07715929 Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in… Phase 4 Not Yet Recruiting
Active Trials by Phase
Phase 4
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07630454 Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With… Atrial Fibrillation Not Yet Recruiting
NCT07715929 Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in… Atrial Fibrillation Not Yet Recruiting
Not specified
NCT07633509 The COMBINE-AF Trial Atrial Fibrillation (AF) Not Yet Recruiting
Disease Areas
Atrial Fibrillation (3) Heart Failure (1) Obesity (1)
Get alerts when Yunlong Wang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free